PPD to Present at the 39th Annual J.P. Morgan Healthcare Conference
PPD will virtually present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 2:50 p.m. ET. The presentation will feature CEO David Simmons and CFO Chris Scully. A live webcast and an archived version, along with presentation slides, will be available for 30 days via PPD's Investor Relations website.
PPD is a global contract research organization offering drug development, laboratory, and lifecycle management services, with over 25,000 professionals in 46 countries.
- None.
- None.
PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, will present virtually at the 39th Annual J.P. Morgan Healthcare Conference. David Simmons, chairman and CEO, and Chris Scully, CFO, are scheduled to present on Monday, Jan. 11, 2021, at 2:50 p.m. (U.S. Eastern Time).
A live and archived webcast of the presentation, along with accompanying slides, will be accessible for up to 30 days through PPD’s Investor Relations website at https://investors.ppd.com.
About PPD
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With locations in 46 countries and more than 25,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health. For more information, visit www.ppd.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210104005457/en/
FAQ
When is PPD's presentation at the J.P. Morgan Healthcare Conference?
Who will be presenting for PPD at the conference?
How can I access the PPD presentation after it occurs?
What services does PPD provide?
In how many countries does PPD operate?
